Microarray-based identification of novel biomarkers in IL-1-mediated diseases

Current Opinion in Immunology

Volumn 19, Issue 6, 2007, Pages 623-632

  Allantaz, Florence ^a   Chaussabel, Damien ^a   Banchereau, Jacques ^a   Pascual, Virginia ^a  

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 1; INTERLEUKIN 6; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA;

AUTOINFLAMMATORY DISEASE; BIOLOGICAL ACTIVITY; CLINICAL FEATURE; CYTOKINE PRODUCTION; DNA CLEAVAGE; GENE EXPRESSION; GENE MUTATION; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE RHEUMATOID ARTHRITIS; MICROARRAY ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; REVIEW; SYNOVIAL FLUID; THROMBOSIS; TISSUE REPAIR; TRANSCRIPTION INITIATION; TRANSLATION INITIATION; VASCULITIS;

ARTHRITIS, JUVENILE RHEUMATOID; BIOLOGICAL MARKERS; DIABETES MELLITUS; GENE EXPRESSION PROFILING; HUMANS; IMMUNE SYSTEM DISEASES; INFLAMMATION; INTERLEUKIN-1; MICROARRAY ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, INTERLEUKIN-1;

EID: 36849057243     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2007.10.003     Document Type: Review

References (73)

1. Smith D.E., Renshaw B.R., Ketchem R.R., Kubin M., Garka K.E., and Sims J.E. Four new members expand the interleukin-1 superfamily. J Biol Chem 275 (2000) 1169-1175
2. Dinarello C.A. Blocking IL-1 in systemic inflammation. J Exp Med 201 (2005) 1355-1359
3. Dinarello C.A. The many worlds of reducing interleukin-1. Arthritis Rheum 52 (2005) 1960-1967
4. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., Zurawski G., Moshrefi M., Qin J., Li X., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23 (2005) 479-490
5. Martinon F., and Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 14 (2007) 10-22. Very comprehensive review on caspases and the different types of inflammasomes.
6. Kanneganti T.D., Body-Malapel M., Amer A., Park J.H., Whitfield J., Franchi L., Taraporewala Z.F., Miller D., Patton J.T., Inohara N., et al. Critical role for cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J Biol Chem 281 (2006) 36560-36568
7. Kanneganti T.D., Ozoren N., Body-Malapel M., Amer A., Park J.H., Franchi L., Whitfield J., Barchet W., Colonna M., Vandenabeele P., et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440 (2006) 233-236. First demonstration that toll-like receptors and cryopyrin control the secretion of IL-1beta and IL-18 through different intracellular pathways.
8. Mariathasan S., Weiss D.S., Newton K., McBride J., O'Rourke K., Roose-Girma M., Lee W.P., Weinrauch Y., Monack D.M., and Dixit V.M. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440 (2006) 228-232. This paper shows that cryopyrin is essential for inflammasome activation in response to signalling pathways triggered specifically by ATP, potassium ionophores, maitotoxin, S. aureus, or L. monocytogenes.
9. Martinon F., Petrilli V., Mayor A., Tardivel A., and Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440 (2006) 237-241. This paper demonstrates that uric acid crystals induce IL-1b-mediated inflammation through direct activation of the inflammasome. It sets the basis for IL-1 blockade in gout.
10. Ferrari D., Pizzirani C., Adinolfi E., Lemoli R.M., Curti A., Idzko M., Panther E., and Di Virgilio F. The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 176 (2006) 3877-3883
11. Petrilli V., Papin S., Dostert C., Mayor A., Martinon F., and Tschopp J. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 14 (2007) 1583-1589
12. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 87 (1996) 2095-2147
13. Martinon F., Gaide O., Petrilli V., Mayor A., and Tschopp J. NALP Inflammasomes: a central role in innate immunity. Semin Immunopathol 29 (2007) 213-229
14. Brydges S., and Kastner D.L. The systemic autoinflammatory diseases: inborn errors of the innate immune system. Curr Top Microbiol Immunol 305 (2006) 127-160. Recent update on hereditary autoinflammatory diseases.
15. Aksentijevich I., Putnam C.D., Remmers E.F., Mueller J.L., Le J., Kolodner R.D., Moak Z., Chuang M., Austin F., Goldbach-Mansky R., et al. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum 56 (2007) 1273-1285
16. Watanabe H., Gaide O., Petrilli V., Martinon F., Contassot E., Roques S., Kummer J.A., Tschopp J., and French L.E. Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol 12 (2007) 1956-1963
17. McDermott M.F., and Tschopp J. From inflammasomes to fevers, crystals and hypertension: how basic research explains inflammatory diseases. Trends Mol Med 13 (2007) 381-388. Recent update on novel mechanisms of inflammasome activation.
18. Sutterwala F.S., Ogura Y., Szczepanik M., Lara-Tejero M., Lichtenberger G.S., Grant E.P., Bertin J., Coyle A.J., Galan J.E., Askenase P.W., et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24 (2006) 317-327
19. Bennett L., Palucka A.K., Arce E., Cantrell V., Borvak J., Banchereau J., and Pascual V. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197 (2003) 711-723
20. Pascual V., Allantaz F., Arce E., Punaro M., and Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 201 (2005) 1479-1486. First paper describing the use of microarrays to understand the pathogenesis of SoJIA.
21. Alizadeh A.A., Eisen M.B., Davis R.E., Ma C., Lossos I.S., Rosenwald A., Boldrick J.C., Sabet H., Tran T., Yu X., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403 (2000) 503-511
22. Bittner M., Meltzer P., Chen Y., Jiang Y., Seftor E., Hendrix M., Radmacher M., Simon R., Yakhini Z., Ben-Dor A., et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406 (2000) 536-540
23. Crow M.K., Kirou K.A., and Wohlgemuth J. Microarray analysis of interferon-regulated genes in SLE. Autoimmunity 36 (2003) 481-490
24. Baechler E.C., Batliwalla F.M., Karypis G., Gaffney P.M., Ortmann W.A., Espe K.J., Shark K.B., Grande W.J., Hughes K.M., Kapur V., et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100 (2003) 2610-2615
25. Achiron A., Feldman A., Mandel M., and Gurevich M. Impaired expression of peripheral blood apoptotic-related gene transcripts in acute multiple sclerosis relapse. Ann N Y Acad Sci 1107 (2007) 155-167
26. Achiron A., Gurevich M., Snir Y., Segal E., and Mandel M. Zinc-ion binding and cytokine activity regulation pathways predicts outcome in relapsing-remitting multiple sclerosis. Clin Exp Immunol 149 (2007) 235-242
27. Singh M.K., Scott T.F., LaFramboise W.A., Hu F.Z., Post J.C., and Ehrlich GD. Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapy. J Neurol Sci 258 (2007) 52-59
28. Edwards C.J., Feldman J.L., Beech J., Shields K.M., Stover J.A., Trepicchio W.L., Larsen G., Foxwell B.M., Brennan F.M., Feldmann M., et al. Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis. Mol Med 13 (2007) 40-58
29. van der Pouw Kraan T.C., Wijbrandts C.A., van Baarsen L.G., Voskuyl A.E., Rustenburg F., Baggen J.M., Ibrahim S.M., Fero M., Dijkmans B.A., Tak P.P., et al. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis 66 (2007) 1008-1014
30. Lequerre T., Gauthier-Jauneau A.C., Bansard C., Derambure C., Hiron M., Vittecoq O., Daveau M., Mejjad O., Daragon A., Tron F., et al. Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis. Arthritis Res Ther 8 (2006) R105
31. Batliwalla F.M., Baechler E.C., Xiao X., Li W., Balasubramanian S., Khalili H., Damle A., Ortmann W.A., Perrone A., Kantor A.B., et al. Peripheral blood gene expression profiling in rheumatoid arthritis. Genes Immun 6 (2005) 388-397
32. Burczynski M.E., Peterson R.L., Twine N.C., Zuberek K.A., Brodeur B.J., Casciotti L., Maganti V., Reddy P.S., Strahs A., Immermann F., et al. Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells. J Mol Diagn 8 (2006) 51-61
33. Stoeckman A.K., Baechler E.C., Ortmann W.A., Behrens T.W., Michet C.J., and Peterson E.J. A distinct inflammatory gene expression profile in patients with psoriatic arthritis. Genes Immun 7 (2006) 583-591
34. Greenberg S.A., Pinkus J.L., Pinkus G.S., Burleson T., Sanoudou D., Tawil R., Barohn R.J., Saperstein D.S., Briemberg H.R., Ericsson M., et al. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 57 (2005) 664-678
35. Baechler E.C., Bauer J.W., Slattery C.A., Ortmann W.A., Espe K.J., Novitzke J., Ytterberg S.R., Gregersen P.K., Behrens T.W., and Reed A.M. An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity. Mol Med 13 (2007) 59-68
36. Lempicki R.A., Polis M.A., Yang J., McLaughlin M., Koratich C., Huang D.W., Fullmer B., Wu L., Rehm C.A., Masur H., et al. Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons. J Infect Dis 193 (2006) 1172-1177
37. Thach D.C., Agan B.K., Olsen C., Diao J., Lin B., Gomez J., Jesse M., Jenkins M., Rowley R., Hanson E., et al. Surveillance of transcriptomes in basic military trainees with normal, febrile respiratory illness, and convalescent phenotypes. Genes Immun 6 (2005) 588-595
38. Ramilo O., Allman W., Chung W., Mejias A., Ardura M., Glaser C., Wittkowski K.M., Piqueras B., Banchereau J., Palucka A.K., et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109 (2007) 2066-2077
39. Simmons C.P., Popper S., Dolocek C., Chau T.N., Griffiths M., Dung N.T., Long T.H., Hoang D.M., Chau N.V., Thao le T.T., et al. Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J Infect Dis 195 (2007) 1097-1107
40. Jacobsen M., Repsilber D., Gutschmidt A., Neher A., Feldmann K., Mollenkopf H.J., Ziegler A., and Kaufmann S.H. Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med 85 (2007) 613-621
41. Ockenhouse C.F., Hu W.C., Kester K.E., Cummings J.F., Stewart A., Heppner D.G., Jedlicka A.E., Scott A.L., Wolfe N.D., Vahey M., et al. Common and divergent immune response signaling pathways discovered in peripheral blood mononuclear cell gene expression patterns in presymptomatic and clinically apparent malaria. Infect Immun 74 (2006) 5561-5573
42. Tang B.M., McLean A.S., Dawes I.W., Huang S.J., and Lin R.C. The use of gene-expression profiling to identify candidate genes in human sepsis. Am J Respir Crit Care Med 176 (2007) 676-684
43. Flechner S.M., Kurian S.M., Head S.R., Sharp S.M., Whisenant T.C., Zhang J., Chismar J.D., Horvath S., Mondala T., Gilmartin T., et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 4 (2004) 1475-1489
44. Martinez-Llordella M., Puig-Pey I., Orlando G., Ramoni M., Tisone G., Rimola A., Lerut J., Latinne D., Margarit C., Bilbao I., et al. Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 7 (2007) 309-319
45. Deng M.C., Eisen H.J., Mehra M.R., Billingham M., Marboe C.C., Berry G., Kobashigawa J., Johnson F.L., Starling R.C., Murali S., et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 6 (2006) 150-160
46. Baron C., Somogyi R., Greller L.D., Rineau V., Wilkinson P., Cho C.R., Cameron M.J., Kelvin D.J., Chagnon P., Roy D.C., et al. Prediction of graft-versus-host disease in humans by donor gene-expression profiling. PLoS Med 4 (2007) e23. This paper describes the identification of markers in lymphocytes isolated from a sizable patient population with GVHD.
47. Takamura T., Honda M., Sakai Y., Ando H., Shimizu A., Ota T., Sakurai M., Misu H., Kurita S., Matsuzawa-Nagata N., et al. Gene expression profiles in peripheral blood mononuclear cells reflect the pathophysiology of type 2 diabetes. Biochem Biophys Res Commun 361 (2007) 379-384
48. Kaizer E.C., Glaser C.L., Chaussabel D., Banchereau J., Pascual V., and White P.C. Gene expression in peripheral blood mononuclear cells from children with diabetes. J Clin Endocrinol Metab 92 (2007) 3705-3711. First paper describing the presence of an IL-1b signature in the blood of newly diagnosed children with type 1 and type 2 diabetes.
49. Tang Y., Xu H., Du X., Lit L., Walker W., Lu A., Ran R., Gregg J.P., Reilly M., Pancioli A., et al. Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab 26 (2006) 1089-1102
50. Solmi R., Ugolini G., Rosati G., Zanotti S., Lauriola M., Montroni I., del Governatore M., Caira A., Taffurelli M., Santini D., et al. Microarray-based identification and RT-PCR test screening for epithelial-specific mRNAs in peripheral blood of patients with colon cancer. BMC Cancer 6 (2006) 250
51. Osman I., Bajorin D.F., Sun T.T., Zhong H., Douglas D., Scattergood J., Zheng R., Han M., Marshall K.W., and Liew C.C. Novel blood biomarkers of human urinary bladder cancer. Clin Cancer Res 12 (2006) 3374-3380
52. Petty R.E., Southwood T.R., Manners P., Baum J., Glass D.N., Goldenberg J., He X., Maldonado-Cocco J., Orozco-Alcala J., Prieur A.M., et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31 (2004) 390-392
53. Adams A., and Lehman T.J. Update on the pathogenesis and treatment of systemic onset juvenile rheumatoid arthritis. Curr Opin Rheumatol 17 (2005) 612-616
54. Gamero A.M., and Oppenheim JJ. IL-1 can act as number one. Immunity 24 (2006) 16-17
55. Allantaz F., Chaussabel D., Stichweh D., Bennett L., Allman W., Mejias A., Ardura M., Chung W., Wise C., Palucka K., et al. Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade. J Exp Med 204 (2007) 2131-2144. This paper describes the identification of a diagnostic signature in SoJIA using blood microarrays and analysis of significance patterns.
56. Chaussabel D., Allman W., Mejias A., Chung W., Bennett L., Ramilo O., Pascual V., Palucka A.K., and Banchereau J. Analysis of significance patterns identifies ubiquitous and disease-specific gene-expression signatures in patient peripheral blood leukocytes. Ann N Y Acad Sci 1062 (2005) 146-154
57. Mandrup-Poulsen T. Apoptotic signal transduction pathways in diabetes. Biochem Pharmacol 66 (2003) 1433-1440
58. Welsh N., Cnop M., Kharroubi I., Bugliani M., Lupi R., Marchetti P., and Eizirik D.L. Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets?. Diabetes 54 (2005) 3238-3244
59. Larsen C.M., Faulenbach M., Vaag A., Volund A., Ehses J.A., Seifert B., Mandrup-Poulsen T., and Donath M.Y. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356 (2007) 1517-1526
60. Shi L., Tong W., Goodsaid F., Frueh F.W., Fang H., Han T., Fuscoe J.C., and Casciano D.A. QA/QC: challenges and pitfalls facing the microarray community and regulatory agencies. Expert Rev Mol Diagn 4 (2004) 761-777. A summary of the efforts and conclusions reached by the microarray quality control program initiated by the FDA.
61. Ioannidis J.P. Microarrays and molecular research: noise discovery?. Lancet 365 (2005) 454-455
62. Michiels S., Koscielny S., and Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 365 (2005) 488-492
63. Cobb J.P., Mindrinos M.N., Miller-Graziano C., Calvano S.E., Baker H.V., Xiao W., Laudanski K., Brownstein B.H., Elson C.M., Hayden D.L., et al. Application of genome-wide expression analysis to human health and disease. Proc Natl Acad Sci U S A 102 (2005) 4801-4806. An overview of the challenges inherent to microarray research in a clinical setting.
64. Bammler T., Beyer R.P., Bhattacharya S., Boorman G.A., Boyles A., Bradford B.U., Bumgarner R.E., Bushel P.R., Chaturvedi K., Choi D., et al. Standardizing global gene expression analysis between laboratories and across platforms. Nat Methods 2 (2005) 351-356
65. Eady J.J., Wortley G.M., Wormstone Y.M., Hughes J.C., Astley S.B., Foxall R.J., Doleman J.F., and Elliott R.M. Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. Physiol Genomics 22 (2005) 402-411
66. Sharma A., Sharma V.K., Horn-Saban S., Lancet D., Ramachandran S., and Brahmachari S.K. Assessing natural variations in gene expression in humans by comparing with monozygotic twins using microarrays. Physiol Genomics 21 (2005) 117-123
67. Allison D.B., Cui X., Page G.P., and Sabripour M. Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet 7 (2006) 55-65. A summary of the prevailing trends in microarray data analysis strategies.
68. Debey S., Schoenbeck U., Hellmich M., Gathof B.S., Pillai R., Zander T., and Schultze J. Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types. Pharmacogenomics J 4 (2004) 193-207
69. Whitney A.R., Diehn M., Popper S.J., Alizadeh A.A., Boldrick J.C., Relman D.A., and Brown PO. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A 100 (2003) 1896-1901
70. Thach D.C., Lin B., Walter E., Kruzelock R., Rowley R.K., Tibbetts C., and Stenger DA. Assessment of two methods for handling blood in collection tubes with RNA stabilizing agent for surveillance of gene expression profiles with high density microarrays. J Immunol Methods 283 (2003) 269-279
71. Debey S., Zander T., Brors B., Popov A., Eils R., and Schultze JL. A highly standardized, robust, and cost-effective method for genome-wide transcriptome analysis of peripheral blood applicable to large-scale clinical trials. Genomics 87 (2006) 653-664
72. Dobbin K., and Simon R. Sample size determination in microarray experiments for class comparison and prognostic classification. Biostatistics 6 (2005) 27-38
73. Seo J., Gordish-Dressman H., and Hoffman E.P. An interactive power analysis tool for microarray hypothesis testing and generation. Bioinformatics 22 (2006) 808-814